Results 131 to 140 of about 76,283 (157)

Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature

Journal of Dermatological Treatment, 2017
Alireza Firooz, Aniseh Samadi, Mansour Nassiri Kashani   +2 more
exaly  

Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs)

Bioorganic and Medicinal Chemistry Letters, 2009
Herbert R Treutlein, Emmanuelle Fantino, Tracy L Nero   +2 more
exaly  

Inhibitors of Janus kinases

2010
MACHACEK MICHELLE R, HAIDLE ANDREW, ZABIEREK ANNA A, KONRAD KALEEN M, ALTMAN MICHAEL D   +4 more
openaire   +4 more sources

Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure

Journal of the American Academy of Dermatology, 2017
James P Strassner, Brett King, John E Harris   +2 more
exaly  

Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis.

Clinical and Experimental Immunology, 2014
K Migita, M Izumi, Y Izumi
exaly  

Janus Kinase

2011
openaire   +1 more source

Pharmacophore and docking-based virtual screening approach for the design of new dual inhibitors of Janus kinase 1 and Janus kinase 2

SAR and QSAR in Environmental Research, 2014
Om Silakari, Haneesh Jasuja
exaly  

INHIBITORS OF JANUS KINASES

2007
YOUNG JONATHAN R, HAIDLE ANDREW, TEMPEST PAUL, MACHACEK MICHELLE   +3 more
openaire   +4 more sources

Clinical significance of Janus Kinase inhibitor selectivity.

Rheumatology, 2019
Ernest Choy
exaly  

Janus Kinases

2008
openaire   +1 more source